Measles vaccine coverage increased in Eastern Mediterranean children but remains below elimination target

An observational study examined progress toward measles elimination in children across the Eastern Mediterranean Region from 2013 to 2018. The analysis tracked the number of children receiving two doses of measles-containing vaccine, though the specific comparator group and sample size were not reported.

The main finding was that the number of children receiving two measles vaccine doses increased during the study period. However, vaccination coverage remained below the World Health Organization's recommended level of 95% or higher, which is considered necessary for measles elimination. The study did not report specific coverage percentages, absolute numbers, effect sizes, or statistical measures for this increase.

No safety or tolerability data regarding the measles vaccine were reported in this analysis. Key limitations include the observational nature of the data, which shows association rather than causation, and the lack of reported specific coverage metrics or effect magnitudes. The study's funding sources and potential conflicts of interest were also not reported.

For practice, this evidence indicates that while vaccination efforts may be expanding in the region, significant gaps persist relative to the threshold required for disease elimination. Clinicians should interpret the reported increase cautiously due to the absence of specific numerical data on coverage levels.